Shanghai Kehua Bio-Engineering's (SHE:002022) specific growth factor assay kit (chemical method) obtained a medical device registration certificate from the food and drug administration of China's Shanghai province, according to a Thursday filing on the Shenzhen Stock Exchange.
The certificate is valid until June 04, 2029, the Chinese medical device maker said.
Shares of the company slipped more than 1% in recent trade.
Price (RMB): ¥6.13, Change: ¥-0.07, Percent Change: -1.13%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments